Tuberculosis and other infections in the anti-tumour necrosis factor-alpha (anti-TNF-α) era

被引：26

作者：

Nacci, Francesca ^{[1
,2
,3
]}

Matucci-Cerinic, Marco ^{[1
,2
,3
]}

机构：

[1] Med & Deno Ctr Univ Florence, Dept Rheumatol AVC, Florence, Italy

[2] Med & Deno Ctr Univ Florence, Dept Biomed, Florence, Italy

[3] Med & Deno Ctr Univ Florence, Div Rheumatol AOUC, Florence, Italy

来源：

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2011年 / 25卷 / 03期

关键词：

Anti-TNF-alpha; Tuberculosis; Infections; ACTIVE RHEUMATOID-ARTHRITIS; FACTOR MONOCLONAL-ANTIBODY; PATIENT-REPORTED OUTCOMES; PEGOL PLUS METHOTREXATE; HEPATITIS-B; LATENT TUBERCULOSIS; FACTOR ANTAGONISTS; DOUBLE-BLIND; MYCOBACTERIUM-TUBERCULOSIS; OPPORTUNISTIC INFECTIONS;

D O I：

10.1016/j.berh.2011.06.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We review the global experience of infections in patients treated with tumour necrosis factor (TNIF)-alpha inhibitors, which shows that the overall incidence of severe infections is at least doubled. In particular, this is true regarding tuberculosis. Screening and prophylactic measures have substantially reduced but not eliminated the risk. Recent improvements in immunologic testing for non-Bacillus Calmette Guerin (BCG)-related antigens allow more sensitive identification of latent tuberculosis and wider use of such methods holds promise as pre-treatment screening instruments. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：375 / 388

页数：14

共 118 条

[1]

ALONSORUIZ A, 2008, BMC MUSCULOSKEL DIS, V17, P9

[2] Specific immune-based diagnosis of tuberculosis [J].

Andersen, P ;

Munk, ME ;

Pollock, JM ;

Doherty, TM .

LANCET, 2000, 356 (9235) :1099-1104

[3]

[Anonymous], 2000, American Journal of Respiratory and Critical Care Medicine, V161, pS221, DOI [10.1164/ajrccm.161.supplement_3.ats600, DOI 10.1164/AJRCCM.161.SUPPLEMENT_3.ATS600]

[4] Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden [J].

Askling, J ;

Fored, CM ;

Brandt, L ;

Baecklund, E ;

Bertilsson, L ;

Cöster, L ;

Geborek, P ;

Jacobsson, LT ;

Lindblad, S ;

Lysholm, J ;

Rantapää-Dahlqvist, S ;

Saxne, T ;

Romanus, V ;

Klareskog, L ;

Feltelius, N .

ARTHRITIS AND RHEUMATISM, 2005, 52 (07) :1986-1992

[5] Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists [J].

Askling, Johan ;

Fored, C. Michael ;

Brandt, Lena ;

Baecklund, Eva ;

Bertilsson, Lennart ;

Feltelius, Nils ;

Coster, Lars ;

Geborek, Pierre ;

Jacobsson, Lennart T. ;

Lindblad, Staffan ;

Lysholm, Jorgen ;

Rantapaa-Dahlqvist, Solbritt ;

Saxne, Tore ;

van Vollenhoven, Ronald F. ;

Klareskog, Lars .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (10) :1339-1344

[6] Long-term treatment with methotrexate or tumor necrosis factor α inhibitors does not increase Epstein-Barr virus load in patients with rheumatoid arthritis [J].

Balandraud, Nathalie ;

Guis, Sandrine ;

Meynard, Jean Baptiste ;

Auger, Isabelle ;

Roudier, Jean ;

Roudier, Chantal .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (05) :762-767

[7] Diagnosing latent tuberculosis infection - The 100-year upgrade [J].

Barnes, PF .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (04) :807-808

[8] QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases [J].

Bartalesi, F. ;

Vicidomini, S. ;

Goletti, D. ;

Fiorelli, C. ;

Fiori, G. ;

Melchiorre, D. ;

Tortoli, E. ;

Mantella, A. ;

Benucci, M. ;

Girardi, E. ;

Cerinic, M. M. ;

Bartoloni, A. .

EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (03) :586-593

[9] Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists [J].

Bergstrom, L ;

Yocum, DE ;

Ampel, NM ;

Villanueva, I ;

Lisse, J ;

Gluck, O ;

Tesser, J ;

Posever, J ;

Miller, M ;

Araujo, J ;

Kageyama, DM ;

Berry, M ;

Karl, L ;

Yung, CM .

ARTHRITIS AND RHEUMATISM, 2004, 50 (06) :1959-1966

[10] Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies [J].

Calabrese, L. H. ;

Zein, N. N. ;

Vassilopoulos, D. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (08) :983-989

← 1 2 3 4 5 6 7 8 9 10 →